Nasser Institute For Research and Treatment   Report issue

Academic/Hospital Phase 2
Founded: Egypt (1987)

Organization Overview

First Clinical Trial
2015
NCT02388035
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Dr Ahmed Ali Elbaz | Nassar institute for research and treatment hospital | Nasser Institute For Research and Treatment

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Peripheral Nervous System Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 6